A Clinical Pharmacology Study of Saxagliptin in Patients With Type 2 Diabetes Mellitus

Phase 3 Completed 20 enrolled Kyowa Kirin, Inc.

NaSingle-groupOpen-labelOther

Summary

The purpose of this study is to evaluate the pharmacokinetics and pharmacodynamics of saxagliptin administered before breakfast for 14 consecutive days in patients with type 2 diabetes mellitus.

Timeline

Start: 2010-07
Primary completion: 2010-11
Completion: 2010-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	SAXAGLIPTIN ANHYDROUS	Small molecule	5 mg	Oral

A Clinical Pharmacology Study of Saxagliptin in Patients With Type 2 Diabetes Mellitus

Summary

Timeline

Drugs

Indications